Sphera Funds Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Sphera Funds Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-449,041	Closed	-$9.57M	–	137
2024 Q1	$9.57M	Sell	449,041 -636,598	-59%	-$7.61M	1.35%	28
2023 Q4	$10.4M	Sell	1,085,639 -268,619	-20%	-$1.31M	1.68%	18
2023 Q3	$3.52M	Buy	1,354,258 +25,000	+2%	+$80.2K	0.64%	55
2023 Q2	$6.21M	Buy	1,329,258 +45,721	+4%	+$198K	0.97%	40
2023 Q1	$4.84M	Buy	+1,283,537	New	+$5.05M	0.81%	45

Sphera Funds Management's FUSN Position: Q2 2024 in Review

Sphera Funds Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 449,041 shares — an estimated $9.57M sold.

Sphera Funds Management first reported a position in FUSN in Q1 2023 and held it in 5 quarters. The position peaked at $10.4M in Q4 2023. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Sphera Funds Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Sphera Funds Management sold 449,041 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $9.57M.
Sphera Funds Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2023 and held it in 5 quarters.
Sphera Funds Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $10.4M in Q4 2023.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Sphera Funds Management's 13F filing for Q2 2024, filed 14 Aug 2024.